Lipocine earnings were -$11.9M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest LPCN earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$2.6M, down 28.6% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, LPCN reported annual earnings of -$9.6M, with -115,371.9% growth. The next LPCN earnings date is Nov 5, 2026.
On LPCN's earnings call on Aug 4, 2026, Lipocine (NASDAQ: LPCN) reported Q2 2026 earnings per share (EPS) of -$0.32, up 21.95% year over year. Total LPCN earnings for the quarter were -$2.62 million. In the same quarter last year, Lipocine's earnings per share (EPS) was -$0.41.
The next LPCN earnings date is Nov 5, 2026. Add LPCN to your watchlist to be reminded of Lipocine's next earnings date.
Is Lipocine profitable or losing money?
As of the last Lipocine earnings report, Lipocine is currently losing money. Lipocine's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$11.85 million, a 162.94% increase year over year.
What was LPCN's earnings growth in the past year?
As of Lipocine's earnings date in Aug 4, 2026, Lipocine's earnings has grown year over year. LPCN earnings in the past year totalled -$11.85 million.
What are Lipocine's earnings expectations?
The current EPS estimate for Lipocine's earnings report in Nov 5, 2026 is -$0.47.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.